Caloric Restriction Exacerbates Renal Post-ischemic Injury and Fibrosis by Modulating MTORC1 Signaling and Autophagy

Overview

Journal Redox Biol

Date 2025 Jan 21

PMID 39837191

Authors

Lang Shi

Hongchu Zha

Juan Zhao

Haiqian An

Hua Huang

Yao Xia

Ziyu Yan

Zhixia Song

Jiefu Zhu

Affiliations

Soon will be listed here.

Abstract

Objective: This study investigates the effects of caloric restriction (CR) on renal injury and fibrosis following ischemia-reperfusion injury (IRI), with a focus on the roles of the mechanistic/mammalian target of rapamycin complex 1 (mTORC1) signaling and autophagy.

Methods: A mouse model of unilateral IRI with or without CR was used. Renal function was assessed through serum creatinine and blood urea nitrogen levels, while histological analysis and molecular assays evaluated tubular injury, fibrosis, mTORC1 signaling, and autophagy activation. Inducible renal tubule-specific Atg7 knockout mice and autophagy inhibitor 3-MA were used to elucidate autophagy's role in renal outcomes.

Results: CR exacerbated renal dysfunction, tubular injury, and fibrosis in IRI mice, associated with suppressed mTORC1 signaling and enhanced autophagy. Rapamycin, an mTORC1 inhibitor, mimicked the effects of CR, further supporting the involvement of mTORC1-autophagy pathway. Tubule-specific Atg7 knockout and autophagy inhibitor 3-MA mitigated these effects, indicating a central role for autophagy in CR-induced renal damage. Glucose supplementation, but not branched-chain amino acids (BCAAs), alleviated CR-induced renal fibrosis and dysfunction by restoring mTORC1 activation. Finally, we identified leucyl-tRNA synthetase 1 (LARS1) as a key mediator of nutrient sensing and mTORC1 activation, demonstrating its glucose dependency under CR conditions.

Conclusion: Our study provides novel insights into the interplay between nutrient metabolism, mTORC1 signaling, and autophagy in IRI-induced renal damages, offering potential therapeutic targets for mitigating CR-associated complications after renal IRI.

References

Shi L, Zha H, Pan Z, Wang J, Xia Y, Li H . DUSP1 protects against ischemic acute kidney injury through stabilizing mtDNA via interaction with JNK. Cell Death Dis. 2023; 14(11):724. PMC: 10630453. DOI: 10.1038/s41419-023-06247-4. View

Deleyto-Seldas N, Efeyan A . The mTOR-Autophagy Axis and the Control of Metabolism. Front Cell Dev Biol. 2021; 9:655731. PMC: 8281972. DOI: 10.3389/fcell.2021.655731. View

Ohsumi Y, Mizushima N . Two ubiquitin-like conjugation systems essential for autophagy. Semin Cell Dev Biol. 2004; 15(2):231-6. DOI: 10.1016/j.semcdb.2003.12.004. View

Benjamin D, Both P, Benjamin J, Nutter C, Tan J, Kang J . Fasting induces a highly resilient deep quiescent state in muscle stem cells via ketone body signaling. Cell Metab. 2022; 34(6):902-918.e6. PMC: 9177797. DOI: 10.1016/j.cmet.2022.04.012. View

Zhang Y, Zhang J, Cui L, Yang S . Autophagy activation attenuates renal ischemia-reperfusion injury in rats. Exp Biol Med (Maywood). 2015; 240(12):1590-8. PMC: 4935330. DOI: 10.1177/1535370215581306. View

Huber T, Walz G, Kuehn E . mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression. Kidney Int. 2010; 79(5):502-11. DOI: 10.1038/ki.2010.457. View

Chen H, Liu C, Cui S, Xia Y, Zhang K, Cheng H . Intermittent fasting triggers interorgan communication to suppress hair follicle regeneration. Cell. 2024; 188(1):157-174.e22. DOI: 10.1016/j.cell.2024.11.004. View

Tang C, Livingston M, Liu Z, Dong Z . Autophagy in kidney homeostasis and disease. Nat Rev Nephrol. 2020; 16(9):489-508. PMC: 7868042. DOI: 10.1038/s41581-020-0309-2. View

Livingston M, Zhang M, Kwon S, Chen J, Li H, Manicassamy S . Autophagy activates EGR1 via MAPK/ERK to induce FGF2 in renal tubular cells for fibroblast activation and fibrosis during maladaptive kidney repair. Autophagy. 2023; 20(5):1032-1053. PMC: 11135847. DOI: 10.1080/15548627.2023.2281156. View

10.

Livingston M, Shu S, Fan Y, Li Z, Jiao Q, Yin X . Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis. Autophagy. 2022; 19(1):256-277. PMC: 9809951. DOI: 10.1080/15548627.2022.2072054. View

11.

Escobar K, Cole N, Mermier C, Vandusseldorp T . Autophagy and aging: Maintaining the proteome through exercise and caloric restriction. Aging Cell. 2018; 18(1):e12876. PMC: 6351830. DOI: 10.1111/acel.12876. View

12.

Makayes Y, Resnick E, Hinden L, Aizenshtein E, Shlomi T, Kopan R . Increasing mTORC1 Pathway Activity or Methionine Supplementation during Pregnancy Reverses the Negative Effect of Maternal Malnutrition on the Developing Kidney. J Am Soc Nephrol. 2021; 32(8):1898-1912. PMC: 8455268. DOI: 10.1681/ASN.2020091321. View

13.

Shi L, Song Z, Li Y, Huang J, Zhao F, Luo Y . MiR-20a-5p alleviates kidney ischemia/reperfusion injury by targeting ACSL4-dependent ferroptosis. Am J Transplant. 2023; 23(1):11-25. DOI: 10.1016/j.ajt.2022.09.003. View

14.

Simon J, Swanson S, Agodoa L, Cruess D, Bohen E, Abbott K . Induction sirolimus and delayed graft function after deceased donor kidney transplantation in the United States. Am J Nephrol. 2004; 24(4):393-401. DOI: 10.1159/000079734. View

15.

Smith K, Wrenshall L, Nicosia R, Pichler R, Marsh C, Alpers C . Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol. 2003; 14(4):1037-45. DOI: 10.1097/01.asn.0000057542.86377.5a. View

16.

Schonig K, Schwenk F, Rajewsky K, Bujard H . Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res. 2002; 30(23):e134. PMC: 137989. DOI: 10.1093/nar/gnf134. View

17.

Marques-Ramos A, Cervantes R . Expression of mTOR in normal and pathological conditions. Mol Cancer. 2023; 22(1):112. PMC: 10349476. DOI: 10.1186/s12943-023-01820-z. View

18.

Takahara T, Amemiya Y, Sugiyama R, Maki M, Shibata H . Amino acid-dependent control of mTORC1 signaling: a variety of regulatory modes. J Biomed Sci. 2020; 27(1):87. PMC: 7429791. DOI: 10.1186/s12929-020-00679-2. View

19.

Behrends C, Sowa M, Gygi S, Harper J . Network organization of the human autophagy system. Nature. 2010; 466(7302):68-76. PMC: 2901998. DOI: 10.1038/nature09204. View

20.

Albano L, Berthoux F, Moal M, Rostaing L, Legendre C, Genin R . Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus. Transplantation. 2009; 88(1):69-76. DOI: 10.1097/TP.0b013e3181aa7d87. View